Hexane

Hexane

SCHEMBL602813

CC(C)O.CCCCCC.CCNCC

nearest known ligand 0.48

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

CCKAR

The experimentally established mechanism targets of Hexane. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 4/20 0.48
TP53 P04637 1/20 0.47
ALDH1A1 P00352 2/20 0.43
SPHK1 Q9NYA1 1/20 0.41
THRB P10828 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.38
MEN1 O00255 3/20 0.38
KMT2A Q03164 3/20 0.38
ADH1B P00325 1/20 0.38
ADH1C P00326 1/20 0.38
ADH1A P07327 1/20 0.38
ADH4 P08319 1/20 0.38
ADH7 P40394 1/20 0.38
FAAH O00519 1/20 0.38
MAPK1 P28482 1/20 0.38
OPRM1 P35372 1/20 0.38
KDM4E B2RXH2 1/20 0.37
TRPA1 O75762 1/20 0.37
DDAH1 O94760 1/20 0.37
GAPDH P04406 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hexane SCHEMBL28417852 0.97 TSHR (0.46) TSHRTP53ALDH1A1SPHK1THRB
Heptane SCHEMBL1920062 0.97 TSHR (0.46) TSHRTP53ALDH1A1SPHK1THRB
Hexane SCHEMBL2397294 0.95 TSHR (0.43) TSHRTP53ALDH1A1SPHK1SMN1; SMN2
Hexane SCHEMBL28467273 0.90 ALDH1A1 (0.52) TSHRTP53ALDH1A1SPHK1SMN1; SMN2
Pentane SCHEMBL28094240 0.89 TSHR (0.43) TSHRTP53ALDH1A1SPHK1SMN1; SMN2
Diethylamine SCHEMBL743633 0.87
Hexane SCHEMBL28226747 0.87 TDP1 (0.50) TSHRTP53ALDH1A1SPHK1SMN1; SMN2
Hexane SCHEMBL28985132 0.86 ADH1B (0.39) TSHRTP53ALDH1A1SMN1; SMN2MEN1
Hexane SCHEMBL28968246 0.86 TSHR (0.37) TSHRTP53ALDH1A1SPHK1MEN1
Hexane SCHEMBL28165252 0.86 TSHR (0.46) TSHRTP53ALDH1A1THRBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 320 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118348148-A High performance liquid chromatography detection method for cinacalcet hydrochloride enantiomer 山东威高药业股份有限公司 2024-07-16 CN claimed
CN-115494174-B Method for detecting thiourea in meloxicam by high performance liquid chromatography 南京瑞孚医药科技有限公司 2024-03-29 CN claimed
CN-115494174-A Method for detecting thiourea in meloxicam by high performance liquid chromatography 南京瑞孚医药科技有限公司 2022-12-20 CN claimed
CN-114839308-A Method for detecting L-tryptophan methyl ester hydrochloride in D-tryptophan methyl ester hydrochloride 江苏天士力帝益药业有限公司 2022-08-02 CN claimed
CN-111983075-A Method for detecting rasagiline and enantiomer thereof 重庆华森制药股份有限公司 2020-11-24 CN claimed
CN-111018723-A Preparation and detection method of dapoxetine hydrochloride isomer impurity 盖天力医药控股集团制药股份有限公司 2020-04-17 CN claimed
CN-106706796-B The method for detecting bortezomib key intermediate 1R- trifluoroacetate optical isomer by high performance liquid chromatography 南京海辰药业股份有限公司 2019-11-19 CN claimed
CN-105997852-B A kind of Rui Jianuosheng injections and preparation method thereof 南京海融医药科技股份有限公司 2018-10-09 CN claimed
CN-106706796-A Method for detecting optical isomer of key intermediate 1R-trifluoroacetate of bortezomib by HPLC (high performance liquid chromatography) 南京海辰药业股份有限公司 2017-05-24 CN claimed
CN-104897833-B A kind of detection method of ACT-064992 intermediate and its application 成都克莱蒙医药科技有限公司 2017-03-01 CN claimed
CN-105997852-A Regadenoson injection and preparation method thereof 南京海融医药科技有限公司 2016-10-12 CN claimed
CN-105968156-A Alpha isomer impurity of regadenoson and preparation method and use thereof 南京海融医药科技有限公司 2016-09-28 CN claimed
CN-104897833-A Detection method for macitentan intermediate and application thereof CHENGDU CLIMB PHARMACEUTICAL TECHNOLOGY CO LTD 2015-09-09 CN claimed
CN-101532996-B Method for analyzing and separating levetiracetam by using HPLC method BEIJING D VENTURE PHARM TECH 2013-12-04 CN claimed
CN-101881755-B Method for detecting esmolol hydrochlorid optical isomer by high efficiency liquid chromatography NANJING HIGHSUN PHARMACEUTICAL CO LTD 2013-05-29 CN claimed
CN-102183589-B Method for detecting contents of dolasetron isomer and salt thereof CHENGDU SINO STRONG PHARMACEUTICAL CO LTD 2013-04-24 CN claimed
CN-101858892-B Method for detecting landiolol hydrochloride optical isomers by high efficiency liquid chromatography NANJING HICIN PHARMACEUTICAL CO LTD 2013-04-10 CN claimed
CN-102183589-A Method for detecting contents of dolasetron isomer and salt thereof CHENGDU SINO STRONG PHARMACEUTICAL CO LTD 2011-09-14 CN claimed
CN-101881755-A Method for detecting esmolol hydrochlorid optical isomer by high efficiency liquid chromatography NANJING HIGHSUN PHARMACEUTICAL CO LTD 2010-11-10 CN claimed
CN-101858892-A Method for detecting landiolol hydrochloride optical isomers by high efficiency liquid chromatography NANJING HICIN PHARMACEUTICAL CO LTD 2010-10-13 CN claimed